Nebraska Hematology Onco, PC — Lincoln, Nebraska

Nebraska Hematology Onco, PC is a clinical research site located in Lincoln, Nebraska, United States 68506.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Hematology Onco, PC has participated in 1 clinical trials.

Therapeutic areas: Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Hematology Onco, PC?

Nebraska Hematology Onco, PC has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Hematology Onco, PC conducted?

Nebraska Hematology Onco, PC has 1 clinical trials on record. Their work covers Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer.

Is Nebraska Hematology Onco, PC accredited by Crixeo Health?

Nebraska Hematology Onco, PC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Hematology Onco, PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.